InsidersTradesSigma
Follow the Alan Stewart share price and the full directors' dealings record of the company, a listed equity based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). Operating in the Health Care sector, Alan Stewart has recorded 2 reports. Market capitalisation: €31.5bn. The latest transaction was filed on 21 May 2026 (Purchase). Among the most active insiders: Haleon plc. The full history is free.
Analysts rate Alan Stewart Buy (bullish), based on 17 analysts. Average price target: £420.82.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Alan Stewart is a company operating in the healthcare and pharmaceutical sector, listed on the London Stock Exchange.